Journal of International Medical Research
The Journal of International Medical Research(JIMR) is an SCIE-ranked peer-reviewed, open access journal that publishes original translational, preclinical and clinical research, systematic and narrative reviews, meta-analyses, protocol studies, validation studies and case reports across all areas of medicine. Please see the aims and scope tab for further information.
Journal Highlights
- Launched in 1972.
- Global visibility due to international audience of multidisciplinary researchers.
- Official Impact Factor is 1.5 (SCIE) (Quarter 3), CiteScore is 3.2.
- Indexed In: Clarivate Analytics: Science Citation Index Expanded (SCIE), PubMed Central (PMC), PubMed: MEDLINE, Scopus, EMBASE, Index Medicus, and the Directory of Open Access Journals (DOAJ).
- Turnaround times (July 2025): Submitted to first decision (i.e. peer reviewer comments to authors) = 53 days; Submitted to accepted = 92 days.
- This journal is a member of the Committee on Publication Ethics (COPE)
- Gold open access journal: all articles are made freely available online on our website and on PubMedCentral.
- Rigorous peer review and decision making with high standards of publication.
- Publication is subject to payment of an article processing charge (APC) that includes high-quality editing of all accepted papers.
- Reviewers get credit for their work via journal partnership with Clarivate Reviewer Recognition (formerly Publons).
Diversity, Equity and Inclusion Statement
The Journal of International Medical Research promotes inclusive, open science that reflects the disciplinary, human, and geographic diversity of the medical research community.
Diversity as a core value embodies inclusiveness, mutual respect, and multiple perspectives.
We welcome editors, editorial board members, peer reviewers and authors from all backgrounds, cultures, ethnicities, nationalities, races, religions, sexes, sexual orientations, gender identities, mental or physical (dis)abilities, ages, career stages, socioeconomic status or any other individual status.
We are committed to continually improving our editorial and review processes whilst playing our part in eradicating bias and inequality in all forms.
Submission Information
Submit your manuscript today at http://mc.manuscriptcentral.com/jimr.
Please see the Submission Guidelines tab for more information on how to submit your article to the journal.
Page Charge Information
Publication in the journal is subject to payment of an APC (Article Processing Charge), which serves to support the journal and ensures that articles are freely accessible online in perpetuity under a Creative Commons license. For all submissions after January 1st 2026, the APC will be $3400 per article. The APC includes a high-quality editing step for all accepted papers. The APC is payable only when a manuscript is accepted after peer review, before it is published. The APC is subject to taxes where applicable. Please see further details here.
Contact
Criteria for Publication
Our goal is to publish research done well. This means we look for research that adds to the academic record, either as novel or corroborative evidence, and adheres to ethical standards, uses robust methodologies that are transparent and reproducible, and uses appropriate statistical analyses to ensure clear, credible, and trustworthy results. The Journal of International Medical Research evaluates manuscripts based on how the research was conducted and reported.
- All manuscripts:
- must comply with the Helsinki Declaration of 1975 and EQUATOR Network reporting guidelines (e.g. CONSORT for randomized, controlled trials, PRISMA for systematic reviews/meta-analyses, STROBE for most observational studies, ARRIVE for animal studies and CARE for case reports).
- are subject to single-blind peer review (comments from at least two external peer reviewers).
- receive high-quality scientific and language editing before publication.
- must follow our publishing policies.
- The journal endorses the ICMJE requirement that clinical trials are registered in a WHO-approved public trials registry at or before the time of first patient enrolment. However, consistent with the AllTrials campaign, retrospectively registered trials will be considered if the justification for late registration is acceptable.
Scope
The Editors are looking for medical research that adds to the existing literature either as novel or corroborative evidence. We will consider replication studies and negative/null results studies.
We welcome manuscripts across the following areas of medicine and health sciences. This includes: allergy and immunology, anaesthesia and analgesia, bioinformatics and computational biology, cardiology, cardiovascular medicine, clinical epidemiology, critical care and emergency medicine, dentistry, dermatology, digital health and medical informatics, endocrinology, diabetes and metabolism, gastroenterology, gene and cell therapy, geriatrics, haematology, health economics and outcomes, hepatology, imaging, men’s health, musculoskeletal, nephrology, neurology, obstetrics and gynaecology, oncology, ophthalmology, otorhinolaryngology, paediatrics and neonatology, pathology, pharmacology, psychiatry, radiology, regenerative medicine, respiratory, surgery, urology and women’s health.
Manuscript types: Original clinical research (randomised controlled trials, observational studies) and preclinical research (in vitro studies, animal studies, in silico studies), systematic reviews and meta-analyses, translational research, study protocols, validation studies, narrative reviews, and case reports/series.
We do not publish the following research:
- Alternative and complementary medicine
- Simple database studies, simple bibliographic studies, common cases
- Studies with limited international appeal that are more suited for a local or niche journal
- Life science and engineering studies: these may be suitable for our sister publication, Science Progress.
You can submit a manuscript at any time. Please also consider our lists of Special Topics and Special Collections.
| Matthew Thorne, PhD (Lead) | SAGE Publications Ltd, UK |
| Michaela Christodoulaki, PhD | SAGE Publications Ltd, UK |
| Sangeetha Thangavelu, PhD | SAGE Publishing, India |
| Lingling Tian, PhD (Consulting) | SAGE Publishing, Shanghai, China |
| Alessandro Perrella | AORN Ospedali dei Colli-Cotugno, Naples, Italy |
| Angel Becerra-Bolaños | Doctor Negrín University Hospital of Gran Canaria, Canary Islands, Spain |
| Hsiang-Ning Luk | Hualien Tzuchi Medical Center, Hualien, Taiwan |
| Tejaswini Arunachala Murthy | University of Adelaide, Adelaide, Australia |
| Joho Tokumine | Kyorin University School of Medicine, Japan |
| Stanley Wong | Hong Kong University, Hong Kong |
| Suleyman Aydin | Firat University, Turkey |
| Sheue-Yann Cheng | National Cancer Institute, Bethesda, USA |
| Shafqat Rasool | McGill University, Montreal, Canada |
| Eser Yildirim Sözmen | Izmir Tinaztepe University, Turkey |
| Haobo Li | Bordeaux Population Health Research Center - INSERM U1219, Bordeaux, France |
| Suresh Kumar Sharma | Panjab University, Chandigarh, India |
| Fuqian Shi | Perlmutter Cancer Center, New York University Langone Health, New York, USA |
| Alexander Berezin | Zaporozhye State Medical University, Ukraine |
| Massimo Bonacchi | University of Florence, Florence, Italy |
| Elizabeth J. Maynes | Uniformed Services University of the Health Sciences, USA |
| Uwe Nixdorff | European Prevention Center, Germany |
| Gaetano Nucifora | University of Manchester/Manchester University NHS Foundation Trust, UK |
| Alessio Rungatscher | University of Verona, Verona, Italy |
| Sayed Ali Sheikh | Jouf University, Aljouf, Sakaka, Kingdom of Saudi Arabia |
| Mehmet Ali Yesiltas | Cemil Tascioglu City Hospital, Istanbul, Turkey |
| Zeyi Cheng | Sichuan University, Chengdu, China |
| Constantine E. Kosmas | National and Kapodistrian University of Athens, University General Hospital “ATTIKON”, Athens, Greece |
| Irfan Shafi | Wayne State University, USA |
| Pasqualino Sirignano | Sapienza University of Rome, Rome, Italy |
| Ying Wang | Wildtype Foods RD&I Department, San Francisco, USA |
| Patrick Meloy | Emory University School of Medicine, Atlanta, GA, USA |
| Ichiro Kurokawa | Meiwa Hospital, Nishinomiya, Hyogo, Japan |
| Tiago Torres | University of Porto, Porto, Portugal |
| Mario Valenti | Humanitas University, Milan, Italy |
| Ernest (Khashayar) Namdar | University of Toronto, Toronto, Canada |
| Fateen Ata | Cleveland Clinic Foundation, Ohio, USA |
| Andrej Belancic | Department of Basic and Clinical Pharmacology and Toxicology, University of Rijeka, Rijeka, Croatia |
| Syed Adeel Hassan | University of Kentucky, Kentucky, USA |
| Jimmy K. Limdi | Northern Care Alliance NHS Foundation Trust & University of Manchester, Manchester, UK |
| Francesco Vasuri | University Hospital of Bologna IRCCS, Italy |
| Jinzhou Zhu | Soochow University, Suzhou, China |
| Tomás José González-López | Hospital Universitario de Burgos, Burgos, Spain |
| Camilla Astley | Rheumatology Division, Clinical Hospital, University of São Paulo, São Paulo, Brazil |
| Yong-Jun Cha | Daejeon University, Republic of Korea |
| Rodrigo Garcia-Salinas | National University of La Plata, Hospital Italiano de La Plata, La Plata, Argentina |
| Giovanni Iolascon | University of Campania "L.Vanvitelli", Italy |
| Hui Luo | The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China |
| Zhengtao Lyu | Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China |
| Antimo Moretti | University of Campania ‘Luigi Vanvitelli’, Caserta, Italy |
| Dionysis Nikolopoulos | Karolinska Institutet, Sweden |
| Nahum Rosenberg | National Insurance Institute, Jerusalem, Israel |
| Babak Shojaie | Bremen-Mitte Hospital, Bremen, Germany |
| Jae Jun Yang | Dongguk University Ilsan Hospital, Goyang, Korea |
| Indranil Dasgupta | University Hospitals Birmingham NHS Foundation Trust, Heartlands Hospital, Birmingham, UK |
| Ali Fahim Khan | University of Oklahoma Health Sciences Center, Oklahoma, USA |
| Giuseppe Lanza | University of Catania, Catania, Italy |
| Anna Lavezzi | University of Milan, Italy |
| Hyun Jung Lee | Chung-Ang University, Seoul, Republic of Korea |
| Jian Liu | Beijing Tian Tan Hospital, Beijing, China |
| Daniele Orsucci | Unit of Neurology, San Luca Hospital of Lucca, Lucca, Italy |
| Wen-Jun Tu | Capital Medical University, China |
| Chien-Chih Wang | Taichung Veterans General Hospital, Taiwan |
| Dimitrios Rafail Kalaitzopoulos | Cantonal Hospital of Schaffhausen, Switzerland |
| Federica Piani | Medical University of Graz, Graz, Austria |
| Deepak Babu | Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, USA |
| Hongwei Cheng | Xiamen University, Xiamen, Fujian, China |
| William Cho | Queen Elizabeth Hospital, Hong Kong |
| Simon Chu | Hudson Institute of Medical Research, Clayton, VIC, Australia |
| José Arnaldo Shiomi da Cruz | University of São Paulo, São Paulo, Brazil |
| Jorge A. Garcia | Case Western Reserve University, Cleveland, OH, USA |
| Matteo Ghilli | University Hospital of Pisa, Pisa, Italy |
| Nicolas Lecomte | David M. Rubenstein CPCR, Memorial Sloan-Kettering Cancer Center, New York, NY, USA |
| Zhaojie Lyu | Peking University Shenzhen Hospital, Shenzhen, China |
| Monia Marchetti | Azienda Ospedaliera Universitaria SS Antonio e Biagio e Cesare Arrigo, Italy |
| Georgios Antonios Margonis | Memorial Sloan Kettering Cancer Center, New York, NY, USA |
| Albiruni Razak | Princess Margaret Cancer Centre, Toronto, Canada |
| Jose Juan Pereyra Rodriguez | Virgen del Rocío University Hospital/ University of Sevilla, Spain |
| Antonio Tufano | Sapienza University of Rome, Rome, Italy |
| Senbang Yao | The Second Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China |
| Theo Empeslidis | Stoneygate Eye Hospital, Leicester, UK |
| Georgios D Panos | Nottingham University Hospitals NHS Trust, Nottingham, UK |
| Francesc March de Ribot | University of Otago, Dunedin University Hospital, Dunedin, New Zealand |
| Mohammad Soleimani | University of Illinois at Chicago, Chicago, IL, USA |
| Francesco Menzella | AULSS2 Marca Trevigiana, Italy |
| Bushra Mina | Northwell Northern Westchester Hospital, Northwell, New York, USA |
| Nuray Bayar Muluk | Kirikkale University, Turkey |
| Luca Roncati | University Hospital of Modena, University of Modena and Reggio Emilia, Italy |
| Madhuradhar Chedongi | University of Iowa, Iowa City, IA, USA |
| Rahul Chodhari | Royal Free London NHS Foundation Trust, London, UK |
| Keiko Hikino | Laboratory for Pharmacogenomics, RIKEN, Yokohama, Japan |
| Róisín Kelly-Laubscher | University College Cork, Cork, Ireland |
| Melissa Badowski | University of Illinois at Chicago, Chicago, IL, USA |
| Rajesh Tampi | Yale School of Medicine, New Haven, CT, USA & Creighton University School of Medicine, Omaha, NE, USA |
| Silvia Gigli | Sandro Pertini Hospital, Via dei Monti Tiburtini, Rome, Italy |
| Agostino Tessitore | ‘G. Martino’ University Hospital of Messina, Messina, Italy |
| Irene Cantarero Carmona | University of Córdoba, Córdoba, Spain |
| Gun Woo Lee | Yeungnam University College of Medicine, Gyeongsan, Republic of Korea |
| Meer Chisthi | Government Medical College, Trivandrum, India |
| Pankaj N. Maheshwari | Fortis Hospital Mulund, Mumbai, India |